Compare Stocks: ZTS, BHC, and ELAN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BHC Bausch Health Cos	$5.86 -3.5%	$5.83	$4.33 ▼ $8.00	$2.27B	0.37	2.60 million shs	2.40 million shs
ELAN Elanco Animal Health	$23.19 +1.5%	$24.54	$18.22 ▼ $27.98	$11.42B	1.68	4.66 million shs	4.74 million shs
ZTS Zoetis	$73.05 +0.3%	$75.56	$71.00 ▼ $150.05	$30.11B	0.73	4.43 million shs	5.24 million shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BHC Bausch Health Cos	-3.43%	-10.47%	-5.56%	+15.83%	-18.17%
ELAN Elanco Animal Health	+1.32%	-5.25%	+4.95%	-4.13%	+26.41%
ZTS Zoetis	+0.07%	-3.50%	-0.57%	-8.13%	-51.12%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BHC Bausch Health Cos	$5.86 -3.5%	$5.83	$4.33 ▼ $8.00	$2.27B	0.37	2.60 million shs	2.40 million shs
ELAN Elanco Animal Health	$23.19 +1.5%	$24.54	$18.22 ▼ $27.98	$11.42B	1.68	4.66 million shs	4.74 million shs
ZTS Zoetis	$73.05 +0.3%	$75.56	$71.00 ▼ $150.05	$30.11B	0.73	4.43 million shs	5.24 million shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BHC Bausch Health Cos	-3.43%	-10.47%	-5.56%	+15.83%	-18.17%
ELAN Elanco Animal Health	+1.32%	-5.25%	+4.95%	-4.13%	+26.41%
ZTS Zoetis	+0.07%	-3.50%	-0.57%	-8.13%	-51.12%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BHC Bausch Health Cos	1.86	Reduce	$8.00	36.64% Upside
ELAN Elanco Animal Health	2.77	Moderate Buy	$29.09	25.42% Upside
ZTS Zoetis	2.32	Hold	$101.08	38.36% Upside

Current Analyst Ratings Breakdown

Latest ZTS, BHC, and ELAN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/9/2026	ZTS Zoetis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
9/4/2026	ELAN Elanco Animal Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
8/25/2026	ZTS Zoetis	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$104.00 ➝ $94.00
8/25/2026	ZTS Zoetis	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$94.00
8/20/2026	ELAN Elanco Animal Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/20/2026	BHC Bausch Health Cos	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/20/2026	ZTS Zoetis	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$85.00 ➝ $80.00
8/11/2026	ZTS Zoetis	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$112.00 ➝ $96.00
8/11/2026	ZTS Zoetis	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$146.00 ➝ $110.00
8/10/2026	ZTS Zoetis	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
8/10/2026	ZTS Zoetis	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$90.00 ➝ $80.00

(Data available from 9/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BHC Bausch Health Cos	$10.27B	0.21	$7.05 per share	0.83	$1.02 per share	5.74
ELAN Elanco Animal Health	$5.02B	2.31	$2.35 per share	9.85	$13.18 per share	1.76
ZTS Zoetis	$9.53B	3.17	$7.59 per share	9.63	$7.56 per share	9.66

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BHC Bausch Health Cos	$157M	-$2.96	N/A	1.46	N/A	-10.12%	-561.95%	6.31%	10/28/2026 (Estimated)
ELAN Elanco Animal Health	-$232M	-$0.41	N/A	18.26	1.71	-3.96%	8.13%	3.99%	11/4/2026 (Estimated)
ZTS Zoetis	$2.67B	$6.07	12.03	11.54	1.70	27.49%	74.89%	18.59%	11/3/2026 (Estimated)

Latest ZTS, BHC, and ELAN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	ZTS Zoetis	$1.85	$1.87	+$0.02	$1.65	$2.50 billion	$2.47 billion
8/5/2026	Q2 2026	ELAN Elanco Animal Health	$0.2692	$0.34	+$0.0708	$0.11	$1.31 billion	$1.37 billion
7/29/2026	Q2 2026	BHC Bausch Health Cos	$0.96	$1.26	+$0.30	$0.68	$2.59 billion	$2.83 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BHC Bausch Health Cos	N/A	N/A	N/A	N/A	N/A
ELAN Elanco Animal Health	N/A	N/A	N/A	N/A	N/A
ZTS Zoetis	$2.12	2.90%	+20.11%	34.93%	14 Years

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BHC Bausch Health Cos	54.68	1.44	1.08
ELAN Elanco Animal Health	0.58	2.05	1.10
ZTS Zoetis	2.87	3.08	1.84

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BHC Bausch Health Cos	78.65%
ELAN Elanco Animal Health	97.48%
ZTS Zoetis	92.80%

Insider Ownership

Company	Insider Ownership
BHC Bausch Health Cos	20.67%
ELAN Elanco Animal Health	1.14%
ZTS Zoetis	0.22%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BHC Bausch Health Cos	20,300	374.14 million	296.81 million	Optionable
ELAN Elanco Animal Health	9,400	499.62 million	493.93 million	Optionable
ZTS Zoetis	14,500	413.22 million	412.32 million	Optionable

ZTS, BHC, and ELAN Headlines

Recent News About These Companies

National Pension Service Raises Stock Holdings in Zoetis Inc. $ZTS

September 12 at 4:16 AM | marketbeat.com

Zoetis Inc. $ZTS Shares Sold by Cidel Asset Management Inc.

September 12 at 4:08 AM | marketbeat.com

Engineers Gate Manager LP Increases Stock Position in Zoetis Inc. $ZTS

September 11 at 4:23 AM | marketbeat.com

California State Teachers Retirement System Acquires 47,041,186 Shares of Zoetis Inc. $ZTS

September 11 at 3:51 AM | marketbeat.com

Tidal Investments LLC Purchases 91,492 Shares of Zoetis Inc. $ZTS

September 10 at 6:08 AM | marketbeat.com

Zoetis (ZTS) Shares Drop After Earnings Revision

September 9 at 6:51 PM | finance.yahoo.com

Zoetis Stock (ZTS) Opinions on Michael Burry Portfolio Update

September 9 at 1:51 PM | quiverquant.comQ

‘Big Short' Michael Burry just updated his portfolio for September

September 9 at 6:08 AM | finbold.comF

71,200 Shares in Zoetis Inc. $ZTS Acquired by VIRGINIA RETIREMENT SYSTEMS ET Al

September 9 at 5:12 AM | marketbeat.com

Zoetis Inc. $ZTS Shares Acquired by Concurrent Investment Advisors LLC

September 9 at 4:07 AM | marketbeat.com

HighTower Advisors LLC Sells 166,492 Shares of Zoetis Inc. $ZTS

September 9 at 4:00 AM | marketbeat.com

HB Wealth Management LLC Boosts Holdings in Zoetis Inc. $ZTS

September 9 at 3:51 AM | marketbeat.com

Carmignac Gestion Buys Shares of 1,575,700 Zoetis Inc. $ZTS

September 8, 2026 | marketbeat.com

Zoetis (ZTS) Shares Drop After Earnings Revision

September 8, 2026 | insidermonkey.com

Amundi Increases Holdings in Zoetis Inc. $ZTS

September 8, 2026 | marketbeat.com

Rep. Gilbert Ray Cisneros, Jr. Sells Off Zoetis Inc. (NYSE:ZTS) Stock

September 8, 2026 | marketbeat.com

Nykredit A S Purchases New Shares in Zoetis Inc. $ZTS

September 6, 2026 | marketbeat.com

Guardian Wealth Management Inc. Takes Position in Zoetis Inc. $ZTS

September 6, 2026 | marketbeat.com

Zoetis Inc. (NYSE:ZTS) Given Average Recommendation of "Hold" by Brokerages

September 6, 2026 | americanbankingnews.com

Zoetis Inc. (NYSE:ZTS) Given Average Rating of "Hold" by Brokerages

September 6, 2026 | marketbeat.com

Zoetis Inc. $ZTS Holdings Cut by Raiffeisen Bank International AG

September 5, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ZTS, BHC, and ELAN Company Descriptions

Bausch Health Cos NYSE:BHC

$5.86 -0.22 (-3.54%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$5.94 +0.09 (+1.52%)

As of 09/11/2026 07:47 PM Eastern

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Elanco Animal Health NYSE:ELAN

$23.19 +0.33 (+1.46%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$22.92 -0.27 (-1.18%)

As of 09/11/2026 07:33 PM Eastern

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Zoetis NYSE:ZTS

$73.05 +0.19 (+0.26%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$73.20 +0.15 (+0.20%)

As of 09/11/2026 08:00 PM Eastern

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZTS, BHC, and ELAN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZTS, BHC, and ELAN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZTS, BHC, and ELAN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ZTS, BHC, and ELAN Company Descriptions

Bausch Health Cos NYSE:BHC

Elanco Animal Health NYSE:ELAN

Zoetis NYSE:ZTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZTS, BHC, and ELAN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZTS, BHC, and ELAN Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZTS, BHC, and ELAN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ZTS, BHC, and ELAN Company Descriptions

Bausch Health Cos NYSE:BHC

Elanco Animal Health NYSE:ELAN

Zoetis NYSE:ZTS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools